Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07446114

Functional Outcomes and Control Using Synchron BCI - Canada

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Synchron, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN)

Detailed description

Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN): The Synchron BCI motor neuroprosthesis is an implanted brain-computer interface indicated for adults with bilateral upper-limb motor impairment, including Motor Neuron Disease. The Synchron BCI is intended to replace the function of motor neurons by detecting, translating and transmitting motor-related brain signals to restore clinically meaningful control of digital devices. The Synchron BCI is an implanted BCI device that interfaces with the brain to enable control of digital devices in individuals with bilateral upper-limb motor impairment. The Synchron BCI is designed to record volitional motor-related neural signals from the sensorimotor cortices and translate these signals into digital motor outputs to enable control of digital devices to improve functional independence. The system includes both implantable and non-implantable components. Implantable components are the Stentrode and the Transceiver.

Conditions

Interventions

TypeNameDescription
DEVICEStentrodeThe Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.

Timeline

Start date
2026-03-18
Primary completion
2026-12-01
Completion
2027-07-01
First posted
2026-03-03
Last updated
2026-04-17

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT07446114. Inclusion in this directory is not an endorsement.